Anonymous
Guest
Anonymous
Guest
strange bedfellows.
Pfizer Inc. (PFE) will spend about $100 million over the next five years on a collaborative effort with several Boston-area medical institutions aimed at more efficiently turning early stage research into potential drug candidates.
The New York-based drug giant is putting the headquarters of its "Centers for Therapeutic Innovation" in Boston in an effort to tap one of the nation's hotbeds for medical research. It is teaming with Beth Israel Deaconess Medical Center, Harvard University and six other local institutions.
Pfizer Inc. (PFE) will spend about $100 million over the next five years on a collaborative effort with several Boston-area medical institutions aimed at more efficiently turning early stage research into potential drug candidates.
The New York-based drug giant is putting the headquarters of its "Centers for Therapeutic Innovation" in Boston in an effort to tap one of the nation's hotbeds for medical research. It is teaming with Beth Israel Deaconess Medical Center, Harvard University and six other local institutions.